Centro de Investigacion Cardiovascular y Metabólica

Tijuana, Estado de Baja California 22500

0 studies enrolling now · 4 studies all time

What they study most

Cardiovascular Diseases, Lipoprotein Disorder, Obesity, Type 2 Diabetes, Type 2 Diabetes Mellitus

Studies at this site

• A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease — Completed
• A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes — Completed
• A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity — Running, not enrolling
• A Study of LY3819469 in Participants With Elevated Lipoprotein(a) [Lp(a)] — Completed